슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan ireland limited - donepezil - orodisperzibilna tableta - donepezil 4,56 mg / 1 tableta - donepezil

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan ireland limited - atorvastatin - filmsko obložena tableta - atorvastatin 20 mg / 1 tableta - atorvastatin

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan ireland limited - atorvastatin - filmsko obložena tableta - atorvastatin 40 mg / 1 tableta - atorvastatin

유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

viatris limited - sildenafil citrat - hipertenzija, pljučnica - urološki - adultstreatment odraslih bolnikih s pljučne arterijske hipertenzije, ki so razvrščene kot funkcijski razred ii in iii, za izboljšanje vadbe zmogljivosti. učinkovitost je bila dokazana pri primarni pljučni hipertenziji in pljučni hipertenziji, povezani z boleznijo vezivnega tkiva. pediatrični populationtreatment pri pediatričnih bolnikih, starih od 1 leta do 17 let, s pljučne arterijske hipertenzije. učinkovitost v smislu izboljšanja telesne zmogljivosti ali pljučne hemodinamike je bila prikazana v primarni pljučni hipertenziji in pljučni hipertenziji, povezani s prirojeno srčno boleznijo (glejte poglavje 5.

유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

viatris limited - tadalafil - hipertenzija, pljučnica - urološki - talmanco je indicirano pri odraslih za zdravljenje pljučne arterijske hipertenzije (pah) uvrščene, ki funkcionalno razreda ii in iii, izboljšati uresničevanje sposobnosti. učinkovitost so pokazali pri idiopatskem pah (ipah) in pri pah, povezani s kolagensko vaskularno boleznijo.

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bortezomib - prašek za raztopino za injiciranje - bortezomib 1 mg / 1 viala - bortezomib

유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotična sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan s.a.s. - vankomicin - prašek za raztopino za infundiranje - vankomicin 1000 mg / 1 viala - vankomicin

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan s.a.s. - vankomicin - prašek za raztopino za infundiranje - vankomicin 1000 mg / 1 viala - vankomicin